abstract |
Adenosine analogue-type A3 receptor agonists having an N6 nitrogen substituted by a group which is usually -CH2-CYCLE, where CYCLE is a specified heteroaromatic group, particularly a pyrridyl or a bicyclic group, for example benzoxazole. Preferred CYCLE moieties are substituted in specified positions by, in particular, halo or methyl and, at another position, a dialkylamine. |